Welcome to the Oncomine Blog
Evaluating NGS technologies for in-house comprehensive genomic profiling
11/13/2024 |
Research
In everyday practice, it is common for pathology labs to evaluate >50% cytological specimens across solid tumors especially in lung and pancreatic...
-
The OncomineWorld Experience from Behind the Curtain
BACKGROUND: There is little to no point in saying that we are all living in an unprecedented time, b... -
Shifting the Paradigm: Broader Patient Access to Personalized Oncology Treatments Hinges on In-House Comprehensive Genomic Testing
We are living in an unprecedented time in the collective fight against cancer, where recent developm...